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Abstract  
Purpose 
Eggs are highly nutritious but concerns over their cholesterol content have led to dietary avoidance among 
many. There are also important international differences in relevant dietary guidance. We conducted the 
first prospective study in China investigating the association of egg consumption, cardiovascular disease 
(CVD) mortality, and a meta-analysis. 
Methods  
We included 28,024 participants without CVD at baseline (2003-8) in Guangzhou Biobank Cohort Study. 
All-cause and CVD mortality were identified through record linkage. We used Cox proportional hazards 
regression. We followed the Meta-analysis Of Observational Studies in Epidemiology reporting guidelines. 
Results  
During 275,343 person-years follow-up (average 9.8 years), we found 2,685 all-cause and 873 CVD deaths. 
We found no significant difference in all-cause mortality between higher (7+ eggs/week) and low 
consumption (<1 egg/week) (adjusted hazard ratio (HR) 1.08, 95% confidence interval (CI) 0.93-1.24), and 
mortality from CVD (0.99, 95% CI 0.76-1.27), ischemic heart disease (IHD) (0.92, 95% CI 0.63-1.36), or 
stroke (0.88, 95% CI 0.57-1.35). The updated meta-analyses including our results showed that 7+ 
eggs/week was not associated with all-cause mortality (HR 1.09, 95% CI 0.997-1.200) or IHD (HR 0.97, 
95% CI 0.90-1.05), but associated with a small reduction in stroke (HR 0.91. 95% CI 0.85-0.98). 
Conclusions  
Eating one egg daily is not associated with increase in CVD or all-cause mortality. The small observed 
reduction in stroke risk need to be confirmed. Our findings support current guidelines recommending eggs 
as part of a healthy diet, and should be considered in other dietary recommendations. (243 words) 
 
Key words: Egg consumption, cardiovascular disease, ischemic heart disease; mortality, stroke 
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Introduction  
Consumption of dietary cholesterol has been associated with elevated serum cholesterol [1] and thus 
hypothesized to increase CVD risk.[2] Eggs have been considered highly nutritious but concerns over its 
high cholesterol content have led to egg avoidance by many people.[3,4] The new 2015 US guidelines no 
longer include a limit for dietary cholesterol, and recommend eggs as part of a healthy diet.[5] Three meta-
analyses (all published in 2013) of prospective cohort studies are cited in the guidelines, but these meta-
analyses do not consistently support a null association or beneficial effects.[6-8] While the amount of 
intake is not specified in the US, the 2016 Chinese Dietary Guidelines recommend to consume 40-50 grams 
of egg products (about one egg) daily. However, dietary guidelines from the World Health Organization 
(WHO) (i.e. the WHO Healthy Diet report),[9] Europe [10] or the UK [11] do not mention egg 
consumption, probably because of the lack of reliable scientific evidence. 
 
One of the 3 meta-analyses above reported a dose-response positive (i.e. harmful) association between egg 
consumption and CVD risk [8] but the other two reported no association.[6,7] Most of the studies included 
were from western populations, with only three from Japan which showed no association with IHD risk but 
a lower risk for stroke mortality in those who consumed eggs daily versus never.[12-14] We have found no 
prospective evidence on egg consumption and CVD events or mortality in Chinese, or from populations in 
other low and middle income countries. Results from a Chinese population may contribute important 
evidence in formulating dietary guidelines regarding egg consumption.  
 
Based on a well-established large cohort of older Southern Chinese people, the Guangzhou Biobank Cohort 
Study (GBCS), we examined the association between egg consumption and CVD/stroke mortality. 
Moreover, to better understand the underlying mechanisms, we also examined the cross-sectional 
association of egg consumption with CVD risk factors using baseline data. We then performed updated 
meta-analyses on the associations of egg consumptions with all-cause mortality and CVD-specific 
outcomes including the new GBCS results. 
 
Methods 
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Study sample  
All participants of the Guangzhou Biobank Cohort Study (GBCS) were recruited from 2003 to 2008. The 
Guangzhou Medical Ethics Committee of the Chinese Medical Association approved the study and all 
participants gave written, informed consent before participation. Details of the GBCS have been reported 
previously.[15] 
 
Briefly, the GBCS is a 3-way collaboration among Guangzhou 12th Hospital and the Universities of Hong 
Kong, China and Birmingham, UK. Recruitment of participants was from “The Guangzhou Health and 
Happiness Association for the Respectable Elders” (GHHARE), a community social and welfare 
organization. GHHARE is unofficially aligned with the municipal government. Membership is open to 
Guangzhou permanent residents aged 50 years or above for a nominal fee of 4 CNY (≈50 US cents) per 
month. GHHARE included about 7% of Guangzhou residents in this age group, with branches in all 10 
districts of Guangzhou, the capital city of Guangdong province in southern China. The baseline 
examination included a face-to-face computer-assisted interview by trained nurses on lifestyle, family and 
personal medical history and assessment of anthropometrics, blood pressure, fasting plasma glucose, lipids 
and inflammatory markers. Reliability and validity of the questionnaire was tested 6 months into 
recruitment by recalling 200 randomly selected subjects for re-interview.[15] 
 
Exposure 
All participants were asked how many eggs they had consumed daily over the past 7 days based on a 
validated food frequency questionnaire (FFQ).[16] The responses were classified as <1, 1-2, 3-4, 5-6, and 
7+ eggs per week.  
 
Outcomes 
For the cross-sectional analysis using baseline data, the study outcomes were CVD risk factors including 
systolic and diastolic blood pressure, lipids (low-density lipoprotein (LDL)-cholesterol, high-density 
lipoprotein (HDL)-cholesterol, triglycerides and total cholesterol), fasting glucose, body mass index (kg/m2) 
and waist circumference.  
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Other study outcomes were death from all-causes and cardiovascular diseases. Causes of death were coded 
according to the 10th revisions of the International Classification of Diseases. The four main outcome 
measures that were examined were deaths from cardiovascular disease, ischemic heart disease, all stroke, 
hemorrhagic stroke and ischemic stroke. For those alive, the censored date was 31 January 2016.  
 
Ascertainment of all-cause and cardiovascular disease mortality  
Information on cause of deaths up to January 2016 was mostly obtained via record linkage with the 
Guangzhou Center for Disease Control and Prevention (GCDC). Causes of death were coded according to 
the 10threvisions of the International Classification of Diseases (ICD) by trained nosologists in each 
hospital. When the death certificates were not issued by medical institutions (and hence might have quality 
issue with the coding), the causes of death were verified by GCDC as part of their quality assurance 
program by cross-checking past medical histories and conducting verbal autopsies. From August 2015 to 
May 2016, ten verbal autopsy meetings were conducted in the Guangzhou 12th Hospital to clarify the 
deaths with unclear causes. A physician panel including 5 chief physicians from various disciplines 
reviewed all available medical records of the individuals and assigned in a standard manner a cause of 
death, with assistance of several epidemiologists for unsettled cases. The mid-point between the date of 
recruitment and the date of first censoring (December 31th, 2012) was used for 9 participants confirmed 
dead at the first follow-up for deaths, but whose exact dates of death were not available. For those alive, as 
registered by the police, records were censored on 31 January 2016.  
 
Potential confounders 
As both the dietary pattern and the CVD prevalence could be influenced by socioeconomic position 
(education, occupation, family income),[17] lifestyle factors (physical activity, alcohol use and 
smoking),[18]and chronic disease history (diabetes, hypertension and dyslipidemia), these factors were 
considered potential confounders and included in the regression model. Moreover, as with other previous 
cohort studies,[7] we also included daily foods/dietary energy intake insensitivity analysis because it could 
confound the associations between egg consumption and CVD risk factors/mortality. As from phase 3 
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(2006), the FFQ was shortened, only participants from the first 2 phases who had a detailed assessment on 
dietary intake could be assessed for food (vegetables, fruits, nuts and milk) and daily nutrient intake 
including total dietary energy, and they were included in the sensitivity analysis.[19] 
 
Updated meta-analyses on egg consumption and risk of mortality 
We conducted a sensitivity analysis on 12,899 participants with stable egg consumption habit during 
baseline (September 2003-January 2008) to the 1st follow-up (March 2008-December 2012) (i.e. within 
about 4 years) to examine the association between egg consumption and CVD risk factors. Moreover, as 
egg consumption in low-to-middle income countries may be associated with higher socioeconomic position, 
we conducted another sensitivity analysis to assess whether the results varied by education level.  
 
We then conducted updated meta-analyses on CVD and all-cause mortality incorporating the GBCS results 
following a review protocol (Meta-analysis Of Observational Studies in Epidemiology).[20] For study 
selection, we included prospective studies with cohort design investigating the association between egg 
consumption and risk of IHD, stroke or all-cause mortality. The three recent meta-analyses involved a 
search of the literature up to March 2012[6], June 2012[7] and December 2012, respectively.[8] Thus, we 
conducted additional literature searches on PubMed and MEDLINE from January 2013 to August 24, 2016 
based on the following main search string: (egg AND (ischemic heart disease OR ischaemic heart disease 
OR coronary heart disease OR stroke OR myocardial infarction OR coronary artery disease OR all-cause 
OR all cause) AND (follow up OR mortality)). We retried 10 articles from PubMed and MEDLINE. Of 
these articles, 8 were excluded for one of the following reasons: 1) was a review article (n=1); 2) did not 
relate egg consumption to an outcome of interest (n=6); or 3) was conducted in patients with diabetes (n=1). 
Details of the studies included are shown in Supplementary Table 5. 
 
We used the relative risks comparing the highest (≥1 egg/day) versus lowest categories (≤1 egg /week or 
never) of egg intake to obtain a summary estimate. The heterogeneity among studies was estimated by the 
Cochran Q test and I2 statistic. Heterogeneity was confirmed with a significance level of P≤0.10. The I2 
statistic describes the percentage of total variation in point estimates that can be attributed to heterogeneity. 
8 
 
We considered heterogeneity to be low if an I2 values of 40% was found.[21] A fixed effect model was 
used in the meta-analysis if the heterogeneity was low, otherwise a random effect model was used. We also 
used funnel plots, Begg adjusted rank correlation test and Egger test to test for the presence of publication 
bias. 
 
Statistical analysis  
Chi-square tests or analysis or variance were used to compare participants’ baseline characteristics by egg 
consumption. Generalized linear modeling was used to assess the association of egg consumption with 
CVD risk factors at baseline, giving mean differences and 95% confidence intervals (CI). The Cox 
proportional hazards model was used to calculate adjusted hazard ratios (HRs) with 95% CI. All potential 
confounders were categorized as in Table 1. Participants who died of any other causes were censored at the 
date of death.[22] Whether an association varied by sex was assessed from the significance of an 
interaction term and the heterogeneity of estimates across strata. As no evidence suggested different 
associations by sex (P values for interaction from 0.45-0.92), all analysis was conducted with both sexes 
combined, adjusted for sex. All statistical analyses were done with Stata version 14.0 (STATA Corp LP), 
and all tests were two-sided with a significance level of 0.05. 
 
Results  
In 30,430 participants of GBCS, after excluding those with missing information on egg consumption 
(n=153), CVD risk factors (n=373) and previous CVD history (n=1,520), and 360 lost to follow-up for vital 
status, 28,024 were included in the main analysis. Of those, 18,707 (67%) with detailed assessment of 
energy intake were included in the sensitivity analysis (ESM Figure 1).  
 
Of the 28,024 participants, 5,868 (21%)reported never or did not consume, and 12,343 (44%), 6,157(22%), 
1,361 (5%) and 2,295 (8%) had consumed 1-2, 3-4, 5-6 and 7+ eggs over the past 7 days, respectively. Of 
those who consumed 7+ eggs/week, 97% consumed an average of one egg per day. During 275,343 person-
years of follow-up (average 9.8 years), we found 2,685 deaths, of which 873 were from CVD which 
included 341 from stroke.  
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Table 1 shows that participants who were men, had higher socioeconomic position (higher family income 
and education level, non-manual occupation), and were never smokers, physically active and current 
alcohol users consumed more eggs (all P<0.01). There was no clear association with sex, age, self-rated 
health or self-reported hypertension or hyperlipidemia, while more self-reported diabetes was found in 
those who had more frequent egg consumption (P<0.001). In 18,707 participants with detailed FFQ data, 
more egg consumption was also associated with higher daily intake of vegetables, fruits, milk and nuts, and 
total energy, protein, fat, fiber, cholesterol and saturated fatty acid, as well as lower daily intake of 
carbohydrate, monounsaturated fatty acid and polyunsaturated fatty acid (all P <0.001).  
 
Table 2 shows that higher egg consumption was negatively associated with SBP, DBP, LDL-cholesterol, 
triglycerides, total cholesterol and BMI, after adjusting for sex, age, education, occupation, family income, 
smoking status, physical activity, alcohol drinking, self-rated health, chronic disease history (diabetes, 
hypertension and dyslipidemia) and dietary foods and energy intake (all P for trend <0.01). No association 
with HDL-cholesterol and waist circumference was found. A sensitivity analysis of 12,899 participants 
with stable egg consumption habit during the 1st follow-up period (i.e., from 2008 to 2012) showed similar 
results (ESM Table 2). 
 
Table 3 shows that egg consumption was not significantly associated with all-cause mortality or mortality 
from any CVDs. Compared with those who ate <1 egg per week, the HR (95% CI) in those with egg 
consumption of 7+/weekwas1.08 (0.93-1.24) for all-cause,0.99 (0.76-1.27) for CVD, 0.92 (0.63-1.36) for 
IHD, 0.88 (0.57-1.35) for stroke, 0.63 (0.28-1.41) for ischemic stroke and 1.31 (0.60-2.84) for hemorrhagic 
stroke. Sensitivity analysis adjusting for intake of fruits, vegetables, milk, nuts and total energy showed 
similarly non-significant results (Table 3), and the results were similar after excluding 61 participants who 
consumed more than 7 eggs per week (ESM Table 4). Moreover, as higher egg consumption was 
associated with higher education in our sample, to further account for confounding by education, we 
conducted sensitivity analysis by education and found similar results showing no association between egg 
consumption and mortality from all-cause, CVD, IHD or stroke (ESM table 3). 
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Our updated search (up to 24th August 2016) on PubMed and MEDLINE found two additional 
studies[23,24] which met the inclusion criteria, in addition to the studies included in the three 2013 meta-
analyses. Therefore, a total of 363,565 participants in nine prospective studies for IHD, 436,088 
participants in nine for stroke, and 853,974 participants in four for all-cause mortality were included in our 
updated meta-analyses, including the present results. The characteristics of the included studies are shown 
in ESM Table 5. The updated meta-analyses showed that frequent egg consumption (7+/week) versus low 
consumption (<1/week) was associated with a 9% (95% CI 2-15%) lower risk of all stroke (Figure 1). 
However, no significant association of egg consumption with IHD mortality (pooled HR 0.97, 95% CI 
0.90-1.05), ischemic stroke (HR 0.91, 95% CI 0.81-1.02), hemorrhagic stroke (HR 0.88, 95% CI 0.68-1.14) 
(Figure 1), or all-cause mortality (HR 1.09, 95% CI 0.997-1.20) (ESM Figure 2) was found. No evidence 
for a significant publication bias was found (P values for Begg’s test from 0.18 to 0.90, and for Egger’s test 
from 0.36 to 0.86) (ESM Figure 3). 
 
Discussion  
In a setting with different dietary and cardiovascular disease patterning from the well-studied Western 
populations, we found no evidence of an association between egg consumption and the risk of CVD or all-
cause mortality. In cross-sectional analyses using baseline data, we found an inverse association between 
egg consumption and LDL-cholesterol, triglycerides and blood pressure, suggesting potential beneficial 
effects. Similar results were observed in sensitivity analysis restricting to participants with similar level of 
egg consumption during the follow-up examination. The potential beneficial effect on the CVD risk factors 
is supported by our updated meta-analyses showing that higher egg consumption was associated with a 
slightly but significantly lower risk of stroke.  
 
As a rich source of dietary cholesterol, egg consumption has been linked to a moderate increase in CVD 
risk. One of the 2013 meta-analysis showed that compared to the lowest category of egg consumption, the 
highest level (7+/week) was significantly associated with a higher risk of CVD by 19%.[8] In contrast, the 
two other meta-analyses did not show adverse effect on CVD.[6,7] The discrepancy is likely due to the 
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inclusion of different studies of various quality. In the first meta-analysis,[8] no study from Asia was 
included, while the other two included three studies from Japan, two reporting results on CHD [12,13] and 
one reporting stroke.[14] These studies from Japan did not support the association of egg intake with the 
risk of CHD,[12,13] but conversely suggested that higher egg consumption tended to reduce the risk of 
stroke.[14] However, no other CVD risk factors except for total cholesterol were assessed in those 
studies.[12-14] Moreover, several trials showed that consumption of 1-2 eggs per day (200-400 mg 
cholesterol) has little [25] or slightly favourable effect on lipid profiles [26-28]. Such minor effects on 
plasma cholesterol are unlikely to have substantial overall impact on the risk of CHD or stroke among 
healthy adults. As most randomized trials had a short follow-up of less than 12 months [29], large cohort 
studies with longer follow-up are needed to provide clearer and more precise estimates for the long-term 
effect of egg consumption [30]. However, among individuals with type 2 diabetes, increased egg intake 
may be associated with higher risks of CHD, although the association varied by study design, diabetes 
definition, exposure measurement, age, control for confounders and follow-up duration [30,31], suggesting 
that the underlying mechanisms need to be explored more in depth. Our study provides complementary 
evidence for the association of egg consumption and other common CVD risk factors in an understudied 
yet major population with a high incidence of stroke mortality. The potential beneficial effects on CVD risk 
factors especially blood pressure observed in our cross-sectional analysis warrant further investigation 
using longitudinal or interventional studies.  
 
Our updated meta-analyses showed a significant negative association of higher egg consumption with the 
risk of stroke. Such significant inverse association was reported in two previous cohort studies from 
different settings.[14,32] One is from the Life Span Study in Japan [14] and the other used data from the 
Third National Health and Nutrition Examination Survey 1988-1994 (NHANES III) in the US.[32] Thus 
our results are consistent and extend the previous studies. In addition, one of the three 2013 meta-analyses 
showed that people with higher egg consumption(≥1 egg/day)also showed a 25% lower risk of hemorrhagic 
stroke.[7] The updated meta-analyses including our results provided a more precise estimate of the 
association between higher egg consumption and stroke risk, with an effect size being similar with the 
previous meta-analysis (both pooled HR=0.91). One possible mechanism for this protective association 
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with stroke may be due to the potential negative association between egg consumption, or more specifically 
protein, and blood pressure,[33] which is supported by the analysis of our baseline data on CVD risk 
factors.  
 
American Dietary Guidelines, Japanese Dietary Guidelines (2015) and the Chinese Dietary Guidelines 
(2016) have dropped the recommendation on cholesterol intake limit. But the change in American Dietary 
Guidelines does not suggest that dietary cholesterol is no longer important to consider when building 
healthy eating patterns. Such withdrawals of dietary cholesterol limit have led to concerns in both the 
public and scientific community [34]. As the removal of the dietary cholesterol recommendation from 
dietary guidelines does not mean that dietary cholesterol is no longer a concern for CVD risk, more 
evidence for the effects of dietary cholesterol consumption from different foods on cardiovascular disease 
and other health outcomes is needed. We did not find evidence for a higher risk of all-cause mortality in 
those who consumed 7+ eggs per week. The HR was attenuated toward the null after further excluding 
those who ate more than 1 egg per day (or 7+ eggs/week). "7+ eggs/week" in the literature, which has no 
upper limit of consumption, could have included excessive egg consumers of 2 or more eggs per day (i.e. 
14+/week), and the proportion of such people can vary in different populations. More precise 
categorization is needed for clarifying dose response relationships and dietary recommendations, depending 
on the numbers of participants and outcome events available. 
 
There are several limitations in our study. First, measurement errors in a study of this kind are inevitable. 
Random errors in measuring egg consumption and other dietary habits would likely have biased the results 
toward the null. Second, information on the cooking methods and the amount of oil and salt added to eggs 
was not available in our study, and some participants might not be aware of the eggs added to other foods. 
As the nutrient contents of eggs alter depending on the cooking methods,[35] different cooking methods 
could influence the association between egg consumption and CVD or CVD risk factors. Third, our 
participants with higher egg intake consumed more protein and fiber but fewer carbohydrates and were 
more likely to have higher socioeconomic status than those with lower egg intake, suggesting residual 
confounding may play a role. However this was different from most of the prospective studies in the West 
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that showed higher egg consumption was associated with lower education level.[30,32] Similar results from 
different settings with different patterns of food consumption may strengthen the causal inference by 
adding consistency despite different potential patterns of confounding. Moreover, to reduce potential 
confounding, we firstly adjusted for multiple indicators of socioeconomic position (education, income and 
occupation), and then conducted sensitivity analysis by stratifying our sample based on education level and 
found similar results (ESM table 3), suggesting education could not fully explain the results. Fourth, 
during the long follow-up, participants might have changed their diets. In our sensitivity cross-sectional 
analysis, we restricted to participants with same levels of egg consumption during baseline to the first 
follow-up and found similar results, suggesting the association between egg consumption and CVD risk 
factors is unlikely explained by changes in consumption during follow up. However, due to the relative 
short period of follow-up and small number of CVD deaths, we could not do prospective analysis in those 
with stable egg consumption habit versus those with changes during follow-up. Fifth, as few participants in 
our sample consumed more than one egg per day, our results could not be generalized to this group. Similar 
concerns applied to the earlier meta-analyses.[6-8] Cohort studies including sufficient number of 
participants with high consumption (i.e. 2+ eggs per day) are warranted. Finally, reverse causality between 
egg consumption and CVD risk factors cannot be fully ruled out in the cross-sectional analysis. For 
example, in developed countries, individuals with hypercholesterolemia were provided health services, 
such as health guidance or education, to prevent further CVD. Eggs have been recognized as a popular 
media symbol for many of the dietary over consumption by the public, as well as the icon for both dietary 
and serum cholesterol. Thus, guidelines on dietary cholesterol intake based on recent epidemiological 
studies that did not find a positive association of egg intake with dietary cholesterol or CVD may not be 
robust. However, our sensitivity analysis excluding participants with poor health status or including 
participants with stable consumption habit during follow-up showed similar results, suggesting reverse 
causality, if any, should not be substantial in our study. 
 
To conclude, egg consumption does not increase CVD and all-cause mortality, and avoiding eggs does not 
reduce such risks. Eating one egg daily or 7 or more weekly could reduce stroke risk slightly, but the 
beneficial effects and dose response relationships at high consumption level, if any, need to be confirmed. 
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Our findings support the US and Chinese guidelines which recommend eggs as part of a healthy diet, and 
should be taken into account in other dietary recommendations. People who consume about an egg a day 
can be reassured.  
(3261 words) 
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Figure 1. Pooled HRs and 95% CIs of ischemic heart disease (IHD), stroke, ischemic stroke and 
hemorrhagic stroke incorporating results from the Guangzhou Biobank Cohort Study (GBCS).  
Note: The pooled estimates were obtained by using a fixed effect model. The dots indicate the adjusted 
HRs from a comparison of the highest category of egg consumption (≥7 eggs/week) with the lowest (<1 
egg/week or never). The size of the square is proportional to the weight of individual study. The horizontal 
lines represent 95% CI. The diamond data markers indicate the pooled HR.  
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Table 1 Baseline characteristics by egg consumption levels in 28,024participants of the Guangzhou 
Biobank Cohort Study first examined from September 2003 to January 2008 
 Egg consumption, number per week  
<1 1-2 3-4 5-6 7+ P-
value  
Number of participants (row 
percentage) 5868 (21) 
12343 
(44) 6157 (22) 1361 (5) 2295 (8) 
- 
Age, years, mean (SD) 62.4 (7.3) 61.4 (7) 61.8 (7) 61.9 (6.9) 62.6 (7.1) <0.001 
Age group, years, %       
50-59 42.1 47.5 44.9 44.8 40.5 <0.001 
60-69 40.0 39.1 40.6 40.3 43.1  
70+ 17.9 13.5 14.5 14.9 16.4  
Sex, % men  26.0 26.7 28.1 29.5 29.5 0.002 
Family income, CNY/year, %       
<10,000 8.8 4.9 5.3 5.0 4.0 <0.001 
10,000-29,999 34.9 31.8 30.7 30.8 33.0  
30,000-49,999 17.9 22.1 21.8 21.6 22.8  
≥50,000 12.8 17.5 18.1 19.0 20.6  
Don’t know  25.7 23.7 24.1 23.6 19.7  
Education, %       
Primary or below 54.6 42.3 39.3 38.0 29.1 <0.001 
Secondary 40.4 50.2 50.3 50.0 53.2  
College or above 5.1 7.5 10.4 12.0 17.8  
Occupation, %       
Manual  69.0 62.5 58.5 56.6 49.3 <0.001 
Non-manual  16.9 21.7 26.2 28.0 36.6  
Others  14.2 15.8 15.3 15.4 14.1  
Smoking status, %       
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Never  79.8 81.7 81.1 80.1 82.6 <0.001 
Former  9.4 8.2 9.0 9.8 9.4  
Current  10.8 10.1 10.0 10.1 8.0  
Physical activity, %       
Inactive 10.9 8.6 6.3 5.4 5.3 <0.001 
Minimally active 42.9 41.5 38.8 40.8 35.5  
Active 46.3 49.9 54.9 53.8 59.3  
Alcohol use, %       
Never  77.0 71.9 70.0 69.7 69.4 <0.001 
Former  3.6 3.7 3.1 2.7 3.6  
Current  19.4 24.4 26.9 27.6 27.0  
Self-rated health, % good  81.6 83.8 83.6 83.5 82.6 0.005 
Self-reported diabetes, % 7.1 7.3 7.5 8.2 10.5 <0.001 
Self-reported 
hypertension, % 22.4 21.5 20.9 17.8 20.1 
0.001 
Self-reported 
hyperlipidemia, % 9.3 10.5 10.0 7.5 10.8 
<0.001 
Vegetable intake†, %     
≤100 g/d 13.9 9.5 6.5 4.9 5.4 <0.001 
101-150 g/d 19.3 16.9 12.3 11.1 9.6  
151-200 g/d 19.9 21.8 19.2 15.8 12.8  
201-250 g/d 13.9 15.7 14.8 17.2 15.7  
251-300 g/d 9.8 11.5 12.7 12.7 11.4  
>300 g/d 23.3 24.6 34.5 38.3 45.2  
Fruit intake†, %       
≤50 g/d 29.6 22.7 18.3 15.7 15.3 <0.001 
51-100 g/d 23.2 22.8 21.2 19.7 17.3  
101-150 g/d 18.9 20.8 19.5 19.6 20.3  
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151-200 g/d 12.3 14.2 16.3 17.3 16.1  
201-250 g/d 6.6 8.6 9.4 11.0 11.6  
>250 g/d 9.5 10.9 15.4 16.6 19.4  
Cow milk intake, %       
None 75.8 68.7 68.6 63.5 65.2 <0.001 
1-3 portions/week 11.9 16.9 15.0 17.0 8.8  
>3 portions/week 12.3 14.4 16.5 19.5 26.1  
Nut intake, %       
None 67.5 59.5 56.9 55.3 53.3 <0.001 
1-3 portions/week 21.9 26.6 28.4 29.4 26.7  
>3 portions/week 10.6 13.9 14.7 15.4 20.0  
Nutrient intakes (energy-adjusted as appropriate)†     
Energy, kcal/day, mean 
(SD) 
1694 
(524) 
1779 
(496) 
1934 
(533) 
2065 
(553) 
2057 
(590) 
<0.001 
Protein‡, g/day 69.6 
(69.2-
70.0) 
71.5 
(71.2-
71.8) 
73.6 
(73.1-
73.9) 
76.3 
(75.5-
77.1) 
78.9 
(78.2-
79.6) 
<0.001 
Carbohydrates‡, g/day 268 (266-
268) 
262 (260-
262) 
261 (259-
261) 
256 (253-
258) 
253 (250-
255) 
<0.001 
Fat‡, g/day 57 (56-57) 58 (57-58) 58 (57-58) 59 (57-60) 59 (58-60) <0.001 
Fiber‡, g/day 12.6 
(12.4-
12.7) 
12.9 
(12.7-
12.9) 
13.5 
(13.3-
13.5) 
13.7 
(13.4-
14.0) 
15.2 
(14.9-
15.4) 
<0.001 
Cholesterol‡, mg/day 132 (129-
134) 
144 (142-
145) 
160 (157-
162) 
186 (181-
189) 
160 (156-
163) 
<0.001 
Saturated fatty acid‡, g/day 
9.7 (9.5-
9.8) 
10.1 
(10.0-
10.2) 
10.0 (9.9-
10.1) 
10.3 
(10.0-
10.5) 
10.9 
(10.6-
11.1) 
<0.001 
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Monounsaturated fatty 
acid‡, g/day 
17.6 (7.3-
17.8) 
17.7 (7.5-
17.8) 
17.0 (6.8-
17.2) 
16.7 (6.2-
17.1) 
16.1 (5.6-
16.4) 
<0.001 
Polyunsaturated fatty 
acid‡, g/day 
13.5 (3.2-
13.7) 
13.3 (3.1-
13.4) 
12.5 (2.2-
12.6) 
11.8 (1.3-
12.2) 
12.3 (1.9-
12.7) 
<0.001 
†: 18,707 participants with data on daily dietary energy intake 
‡: Energy adjusted mean and 95% confidence interval (CI). 
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Table 2 Cross-sectional analysis of the association of egg consumption with cardiovascular risk factors in 28,024 participants based on baseline information 
collected from September 2003 to January 2008. 
 Egg consumption, number per week   
 <1 1-2 3-4 5-6 7+ P for trend  
Systolic blood pressure, mmHg       
Crude Reference (0) 2.34 (1.66, 3.02) -0.47 (-1.14, 0.2) -1.73 (-2.96, -0.51)** -1.62 (-2.59, -0.65)*** <0.001 
Model 1 Reference (0) 1.13 (0.51, 1.76) -0.54 (-1.15, 0.08) -1.34 (-2.46, -0.21)* -1.74 (-2.64, -0.84)*** <0.001 
Model 2† Reference (0) 0.92 (0.16, 1.69) -0.8 (-1.55, -0.04)* -1.64 (-2.94, -0.34)* -2.4 (-3.57, -1.24)*** <0.001 
Model 3† Reference (0) -0.79 (-1.56, -0.02)* -1.77 (-2.67, -0.87)* -2.58 (-3.97, -1.18)* -3.32 (-4.6, -2.04)*** <0.001 
Diastolic blood pressure, mmHg Reference (0)      
Crude Reference (0) 0.66 (0.31, 1) -0.15 (-0.49, 0.19) -0.76 (-1.39, -0.14)* -1.07 (-1.57, -0.58)*** <0.001 
Model 1 Reference (0) 0.58 (0.24, 0.91) -0.04 (-0.36, 0.29) -0.42 (-1.02, 0.18) -0.69 (-1.16, -0.21)** <0.001 
Model 2† Reference (0) 0.49 (0.09, 0.9)* -0.13 (-0.53, 0.27) -0.51 (-1.2, 0.17) -1.00 (-1.62, -0.39)*** <0.001 
Model 3† Reference (0) -0.42 (-0.83, -0.01)* -0.64 (-1.12, -0.16)* -0.98 (-1.72, -0.24)* -1.50 (-2.18, -0.82)*** <0.001 
LDL-cholesterol, mmol/l Reference (0)      
Crude Reference (0) -0.01 (-0.04, 0.01) -0.05 (-0.07, -0.02)*** -0.09 (-0.13, -0.05)*** -0.08 (-0.11, -0.05)*** <0.001 
Model 1 Reference (0) 0 (-0.02, 0.02) -0.04 (-0.06, -0.02)*** -0.07 (-0.11, -0.03)*** -0.07 (-0.1, -0.04)*** <0.001 
Model 2† Reference (0) -0.01 (-0.04, 0.01) -0.04 (-0.06, -0.01)** -0.05 (-0.09, -0.004)*' -0.08 (-0.12, -0.04)*** <0.001 
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Model 3† Reference (0) 0.01 (-0.02, 0.03) -0.03 (-0.06, 0.002) -0.04 (-0.08, 0.01) -0.07 (-0.11, -0.02)** <0.001 
HDL-cholesterol, mmol/l Reference (0)      
Crude Reference (0) 0.0004 (-0.01, 0.01) 0.002 (-0.01, 0.01) -0.02 (-0.05, -0.001)* 0.002 (-0.02, 0.02) 0.42 
Model 1 Reference (0) -0.001 (-0.01, 0.01) 0.0007 (-0.01, 0.01) -0.03 (-0.05, -0.004)* -0.003 (-0.02, 0.01) 0.38 
Model 2† Reference (0) 0.002 (-0.01, 0.02) -0.001 (-0.02, 0.01) -0.03 (-0.06, -0.01)* 0.005 (-0.02, 0.03) 0.38 
Model 3† Reference (0) -0.01 (-0.02, 0.01) -0.01 (-0.03, 0.01) -0.04 (-0.07, -0.02)* -0.001 (-0.03, 0.02) 0.32 
Triglycerides, mmol/l Reference (0)      
Crude Reference (0) 0.06 (0.02, 0.1)** -0.05 (-0.09, -0.01)** -0.05 (-0.12, 0.02) -0.09 (-0.14, -0.03)*** <0.001 
Model 1 Reference (0) 0.06 (0.02, 0.1)** -0.04 (-0.08, -0.003)* -0.01 (-0.07, 0.06) -0.07 (-0.12, -0.01)* <0.001 
Model 2† Reference (0) 0.05 (0.01, 0.1)* -0.04 (-0.08, 0.01) 0.01 (-0.07, 0.09) -0.08 (-0.15, -0.01)* 0.001 
Model 3† Reference (0) -0.05 (-0.1, -0.002)* -0.09 (-0.14, -0.03) -0.04 (-0.13, 0.04) -0.14 (-0.21, -0.06)* <0.001 
Total cholesterol, mmol/l Reference (0)      
Crude Reference (0) -0.02 (-0.05, 0.02) -0.06 (-0.09, -0.02)** -0.1 (-0.16, -0.03)** -0.14 (-0.19, -0.09)*** <0.001 
Model 1 Reference (0) -0.01 (-0.05, 0.02) -0.05 (-0.08, -0.01)** -0.07 (-0.13, -0.005)* -0.13 (-0.18, -0.08)*** <0.001 
Model 2† Reference (0) -0.01 (-0.06, 0.03) -0.05 (-0.09, -0.01)* -0.07 (-0.15, 0.0004) -0.11 (-0.17, -0.04)** 0.001 
Model 3† Reference (0) 0.002 (-0.04, 0.05) -0.04 (-0.1, 0.01) -0.07 (-0.15, 0.01) -0.10 (-0.17, -0.03)** 0.001 
Fasting glucose, mmol/l Reference (0)      
Crude Reference (0) 0.01 (-0.04, 0.06) 0.02 (-0.03, 0.07) 0.06 (-0.03, 0.16) 0.10 (0.03, 0.18)** 0.02 
26 
 
Model 1 Reference (0) -0.01 (-0.06, 0.04) 0.01 (-0.04, 0.05) 0.04 (-0.04, 0.12) 0.02 (-0.05, 0.08) 0.27 
Model 2† Reference (0) 0.01 (-0.05, 0.07) 0.04 (-0.02, 0.1) 0.05 (-0.04, 0.15) 0.05 (-0.03, 0.14) 0.15 
Model 3† Reference (0) 0.003 (-0.05, 0.06) 0.03 (-0.04, 0.09) 0.03 (-0.07, 0.14) 0.04 (-0.06, 0.13) 0.24 
Body mass index, kg/m2 Reference (0)      
Crude Reference (0) -0.01 (-0.11, 0.09) -0.21 (-0.31, -0.11)*** -0.24 (-0.43, -0.06)** -0.32 (-0.46, -0.17)*** <0.001 
Model 1 Reference (0) 0.001 (-0.1, 0.1) -0.18 (-0.27, -0.08)** -0.09 (-0.28, 0.09) -0.21 (-0.36, -0.07)** <0.001 
Model 2† Reference (0) -0.07 (-0.19, 0.05) -0.19 (-0.31, -0.07)** -0.11 (-0.32, 0.1) -0.28 (-0.47, -0.1)** 0.005 
Model 3† Reference (0) 0.06 (-0.06, 0.19) -0.17 (-0.32, -0.03)** -0.07 (-0.29, 0.15) -0.29 (-0.50, -0.09)** 0.006 
Waist circumference, cm Reference (0)      
Crude Reference (0) 0.39 (0.11, 0.66) -0.13 (-0.4, 0.15) -0.37 (-0.87, 0.13) -0.07 (-0.47, 0.32) 0.06 
Model 1 Reference (0) 0.16 (-0.11, 0.43) -0.18 (-0.44, 0.08) -0.23 (-0.71, 0.25) -0.06 (-0.45, 0.32) 0.08 
Model 2† Reference (0) 0.05 (-0.27, 0.37) -0.27 (-0.58, 0.05) -0.40 (-0.94, 0.14) -0.16 (-0.64, 0.33) 0.08 
Model 3† Reference (0) -0.002 (-0.32, 0.32) -0.38 (-0.75, -0.01) -0.48 (-1.06, 0.10) -0.35 (-0.89, 0.18) 0.12 
Model 1: adjusted for sex, age, education, occupation, family income, smoking status, physical activity, alcohol drinking, self-rated health and chronic disease 
history (diabetes, hypertension and dyslipidemia).  
Model 2 †: Additionally adjusted for daily dietary energy intake 
Model 3 †: Additionally adjusted for vegetable, fruit, milk and nut intake 
†:18,707participants with data on daily dietary energy intake were included in Model 2&3.  
*: P<0.05; **: P<0.01; ***: P<0.001  
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Table 3.Adjusted hazards ratios (HR) and 95% confidence interval (CI)of all-cause mortality bybaselineeggconsumptionin28,024participants in 2003-2008 and 
followed up until January 2016 
 Egg consumption, number per week  
 <1 1-2 3-4 5-6 7+ P for trend  
Person-years 57396 120827 60974 13800 22345  
All-cause       
No. of deaths 611 1119 579 127 244  
Mortality rate, per 10,000 person-year 106.5 92.6 95 92 109.2  
Adjusted HR (95% CI) 1.00 0.99 (0.9, 1.1) 0.99 (0.89, 1.1) 0.89 (0.73, 1.07) 1.08 (0.93, 1.24) 0.73 
‡Adjusted HR (95% CI) 1.00 1.01 (0.9, 1.14) 0.98 (0.85, 1.12) 0.94 (0.76, 1.17) 1.11 (0.93, 1.33) 0.89 
Cardiovascular disease        
No. of deaths 201 371 185 40 76  
Mortality rate, per 10,000 person-year 35 30.7 30.3 29 34  
Adjusted HR (95% CI) 1.00 0.92 (0.77, 1.1) 0.96 (0.8, 1.14) 0.81 (0.58, 1.14) 0.99 (0.76, 1.27) 0.99 
‡Adjusted HR (95% CI) 1.00 1.14 (0.93, 1.4) 1.07 (0.84, 1.35) 0.96 (0.66, 1.41) 1.05 (0.76, 1.45) 0.98 
Ischemic heart disease        
No. of deaths 83 166 90 16 33  
Mortality rate, per 10,000 person-year 14.5 13.7 14.8 11.6 14.8  
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Adjusted HR (95% CI) 1.00 0.86 (0.66, 1.13) 1.03 (0.79, 1.34) 0.75 (0.44, 1.27) 0.92 (0.63, 1.36) 0.88 
‡Adjusted HR (95% CI) 1.00 1.24 (0.91, 1.69) 1.21 (0.85, 1.72) 0.97 (0.54, 1.76) 1.23 (0.77, 1.97) 0.93 
All Stroke        
No. of deaths 84 146 69 16 26  
Mortality rate, per 10,000 person-year 14.6 12.1 11.3 11.6 11.6  
Adjusted HR (95% CI) 1.00 0.99 (0.75, 1.3) 0.9 (0.68, 1.2) 0.81 (0.47, 1.38) 0.88 (0.57, 1.35) 0.38 
‡Adjusted HR (95% CI) 1.00 1.14 (0.83, 1.56) 0.99 (0.68, 1.44) 0.86 (0.47, 1.57) 0.82 (0.47, 1.43) 0.39 
Ischemic stroke        
No. of deaths 20 52 27 3 7  
Mortality rate, per 10,000 person-year 3.5 4.3 4.4 2.2 3.1  
Adjusted HR (95% CI) 1.00 0.72 (0.43, 1.21) 0.94 (0.59, 1.52) 0.43 (0.13, 1.38) 0.63 (0.28, 1.41) 0.54 
‡Adjusted HR (95% CI) 1.00 1.48 (0.81, 2.69) 1.64 (0.85, 3.18) 0.52 (0.12, 2.29) 1.07 (0.40, 2.84) 0.77 
Hemorrhagic stroke        
No. of deaths 26 35 24 4 8  
Mortality rate, per 10,000 person-year 4.5 2.9 3.9 2.9 3.6  
Adjusted HR (95% CI) 1.00 1.18 (0.7, 1.99) 1.37 (0.81, 2.3) 0.95 (0.34, 2.68) 1.31 (0.60, 2.84) 0.67 
‡Adjusted HR (95% CI) 1.00 1.08 (0.57, 2.04) 1.26 (0.62, 2.55) 1.02 (0.33, 3.14) 0.93 (0.33, 2.67) 0.78 
Ischemic heart disease/ischemic stroke       
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No. of deaths 103 218 117 19 40  
Mortality rate, per 10,000 person-year 17.9 18 19.2 13.8 17.9  
Adjusted HR (95% CI) 1.00 0.83 (0.65, 1.05) 1.01 (0.8, 1.27) 0.67 (0.41, 1.08) 0.85 (0.60, 1.21) 0.87 
‡Adjusted HR (95% CI) 1.00 1.28 (0.97, 1.69) 1.29 (0.95, 1.76) 0.87 (0.5, 1.51) 1.20 (0.78, 1.83) 0.96 
†: adjusted for sex, age, education, occupation, family income, smoking status, physical activity, alcohol drinking, self-rated health and chronic disease history 
(diabetes, hypertension and dyslipidemia).  
‡: Adjusted HR in18,707 participants with data on daily dietary energy and vegetable, fruit, milk and nut intake were included in this model with additional 
adjustment for total energy, vegetable, fruit, milk and nut intake. 
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ESM Table 1. ICD-10 codes for deaths from cardiovascular disease 
Causes of deaths ICD-10 
Cardiovascular disease  I00-I25, I28-I99 
Ischemic heart disease  I20-I25 
Stroke I60-I69 
Ischemic stroke I63 
Hemorrhagic stroke  I61 
Ischemic heart disease or ischemic stroke I20-I25, I63 
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ESM Table 2 Cross-sectional analysis of the association of egg consumption with cardiovascular risk factors in 28,024 participants based on baseline information 
collected from September 2003 to January 2008; regression coefficient β, (95% confidence interval). 
 Egg consumption, numberper week   
 <1 1-2 3-4 5-6 7+ P for trend  
Systolic blood pressure, mmHg       
Crude Reference (0) 2.34 (1.66, 3.02)** -0.47 (-1.14, 0.2) -1.73 (-2.96, -0.51)** -1.62 (-2.59, -0.65)*** <0.001 
Model 1 Reference (0) -1.07 (-1.69, -0.44)* -1.45 (-2.17, -0.73)* -2.44 (-3.62, -1.26)** -2.56 (-3.54, -1.59)*** <0.001 
Model 2† Reference (0) -0.94 (-1.7, -0.17)* -1.57 (-2.45, -0.69)* -2.62 (-3.99, -1.24)** -3.05 (-4.3, -1.79)*** <0.001 
Model 3† Reference (0) -0.86 (-1.63, -0.1)* -1.58 (-2.46, -0.7)* -2.52 (-3.9, -1.15)** -3.01 (-4.27, -1.75)*** <0.001 
Diastolic blood pressure, mmHg       
Crude Reference (0) -0.64 (-0.99, -0.29)* -0.79 (-1.19, -0.39)* -1.42 (-2.09, -0.76)* -1.67 (-2.22, -1.13)*** <0.001 
Model 1 Reference (0) -0.55 (-0.88, -0.22)* -0.46 (-0.85, -0.08)* -0.94 (-1.57, -0.32)* -1.06 (-1.58, -0.55)* <0.001 
Model 2† Reference (0) -0.51 (-0.91, -0.11)* -0.51 (-0.98, -0.05)* -0.99 (-1.72, -0.27)* -1.3 (-1.97, -0.64)** <0.001 
Model 3† Reference (0) -0.46 (-0.87, -0.06)* -0.52 (-0.99, -0.06)* -0.95 (-1.68, -0.23)* -1.3 (-1.97, -0.64)** <0.001 
LDL-cholesterol, mmol/l       
Crude Reference (0) 0.01 (-0.01, 0.03) -0.03 (-0.06, -0.01)* -0.07 (-0.12, -0.03)* -0.07 (-0.1, -0.03)* <0.001 
Model 1 Reference (0) 0.001 (-0.02, 0.02) -0.04 (-0.06, -0.01)* -0.06 (-0.1, -0.02)* -0.07 (-0.1, -0.03)* <0.001 
Model 2† Reference (0) 0.01 (-0.01, 0.04) -0.03 (-0.06, 0.004) -0.03 (-0.08, 0.01) -0.07 (-0.11, -0.03)* <0.001 
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Model 3† Reference (0) 0.01 (-0.02, 0.03) -0.03 (-0.06, 0.003) -0.03 (-0.08, 0.01) -0.06 (-0.11, -0.02)* <0.001 
HDL-cholesterol, mmol/l       
Crude Reference (0) -0.0005 (-0.01, 0.01) 0.0002 (-0.01, 0.01) -0.03 (-0.05, -0.002)* -0.004 (-0.02, 0.02) 0.42 
Model 1 Reference (0) 0.001 (-0.01, 0.01) -0.004 (-0.02, 0.01) -0.03 (-0.05, -0.01)* -0.01 (-0.03, 0.01) 0.38 
Model 2† Reference (0) -0.002 (-0.02, 0.01) -0.01 (-0.03, 0.009) -0.04 (-0.07, -0.01)* -0.003 (-0.03, 0.02) 0.38 
Model 3† Reference (0) -0.01 (-0.02, 0.01) -0.01 (-0.03, 0.006) -0.04 (-0.07, -0.02)** -0.01 (-0.03, 0.02) 0.32 
Triglycerides, mmol/l       
Crude Reference (0) -0.06 (-0.1, -0.02)* -0.11 (-0.15, -0.06)** -0.11 (-0.19, -0.04)** -0.15 (-0.21, -0.09)** <0.001 
Model 1 Reference (0) -0.06 (-0.1, -0.02)* -0.09 (-0.13, -0.05)** -0.06 (-0.13, 0.01) -0.12 (-0.18, -0.06)** <0.001 
Model 2† Reference (0) -0.06 (-0.1, -0.01)* -0.08 (-0.14, -0.03)* -0.04 (-0.12, 0.04) -0.12 (-0.2, -0.05)* 0.001 
Model 3† Reference (0) -0.05 (-0.1, -0.01)* -0.08 (-0.13, -0.03)** -0.03 (-0.12, 0.05) -0.12 (-0.19, -0.04)* <0.001 
Total cholesterol, mmol/l       
Crude Reference (0) 0.01 (-0.02, 0.05) -0.05 (-0.09, 0.001) -0.08 (-0.15, -0.01)* -0.13 (-0.19, -0.08)** <0.001 
Model 1 Reference (0) 0.01 (-0.03, 0.04) -0.04 (-0.08, 0.001) -0.05 (-0.12, 0.01) -0.12 (-0.18, -0.07)** 0.002 
Model 2† Reference (0) 0.01 (-0.03, 0.05) -0.04 (-0.09, 0.01) -0.06 (-0.14, 0.02) -0.1 (-0.17, -0.03)* 0.06 
Model 3† Reference (0) 0.002 (-0.04, 0.05) -0.04 (-0.09, 0.01) -0.06 (-0.14, 0.02) -0.1 (-0.17, -0.02)* 0.06 
Fasting glucose, mmol/l       
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Crude Reference (0) -0.01 (-0.06, 0.05) 0.01 (-0.05, 0.07) 0.06 (-0.04, 0.15) 0.1 (0.02, 0.18)* 0.02 
Model 1 Reference (0) 0.02 (-0.03, 0.06) 0.03 (-0.02, 0.09) 0.06 (-0.03, 0.15) 0.05 (-0.02, 0.12) 0.27 
Model 2† Reference (0) 0.001 (-0.06, 0.06) 0.05 (-0.02, 0.11) 0.05 (-0.05, 0.16) 0.08 (-0.02, 0.17) 0.15 
Model 3† Reference (0) 0.003 (-0.06, 0.06) 0.04 (-0.03, 0.1) 0.04 (-0.06, 0.14) 0.05 (-0.04, 0.15) 0.24 
Body mass index, kg/m2       
Crude Reference (0) -0.01 (-0.11, 0.09) -0.21 (-0.31, -0.11)*** -0.24 (-0.43, -0.06)** -0.32 (-0.46, -0.17)*** <0.001 
Model 1 Reference (0) 0.001 (-0.1, 0.1) -0.18 (-0.27, -0.08)** -0.09 (-0.28, 0.09) -0.21 (-0.36, -0.07)** <0.001 
Model 2† Reference (0) -0.07 (-0.19, 0.05) -0.19 (-0.31, -0.07)** -0.11 (-0.32, 0.1) -0.28 (-0.47, -0.1)** 0.005 
Model 3† Reference (0) 0.06 (-0.06, 0.19) -0.17 (-0.32, -0.03)** -0.07 (-0.29, 0.15) -0.29 (-0.50, -0.09)** 0.006 
Waist circumference, cm       
Crude Reference (0) -0.36 (-0.64, -0.08)* -0.49 (-0.81, -0.16)* -0.71 (-1.24, -0.18)* -0.42 (-0.86, 0.01) 0.06 
Model 1 Reference (0) -0.13 (-0.29, 0.03) 0.06 (-0.12, 0.25) -0.15 (-0.45, 0.15) 0.25 (0.0001, 0.5)* 0.08 
Model 2† Reference (0) -0.175 (-0.36, 0.01) -0.03 (-0.24, 0.19) -0.33 (-0.67, 0.001) 0.24 (-0.07, 0.55) 0.08 
Model 3† Reference (0) -0.14 (-0.32, 0.05) -0.01 (-0.23, 0.2) -0.31 (-0.64, 0.03) 0.26 (-0.05, 0.56) 0.12 
Model 1: adjusted for sex, age, education, occupation, family income, smoking status, physical activity, alcohol drinking, body mass index (except for BMI 
above) , self-rated health and chronic disease history (diabetes, hypertension and dyslipidemia), as appropriate.  
Model 2 †: Additionally adjusted for daily dietary energy intake 
Model 3 †: Additionally adjusted for vegetable, fruit, milk and nut intake 
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†:18,707participants with data on daily dietary energy intake were included in Model 2&3.  
*: P<0.05; **: P<0.01; ***: P<0.001 
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ESM Table 3. Cross-sectional analysis of the association of egg consumption with cardiovascular risk factors in 12,899 participants with stable egg consumption 
habit during the 1st follow-up 
 Egg consumption, number per week  
 <1 
(n=2,208) 
1-2 
(n=6,761) 
3-4 
(n=3,033) 
5-6 
(n=441) 
7+ 
(n=456)  
P for trend  
Systolic blood pressure, mmHg       
Crude Reference (0) 2.05 (1.02, 3.07)** -0.96 (-1.88, -0.05)* -2.68 (-4.74, -0.63)* -1.88 (-3.89, 0.14) <0.001 
Model 1† Reference (0) 0.77 (-0.18, 1.72) -0.78 (-1.62, 0.06) -1.9 (-3.79, -0.01)* -2.25 (-4.09, -0.4)* <0.001 
Diastolic blood pressure, mmHg       
Crude Reference (0) 0.65 (0.12, 1.18)* -0.31 (-0.78, 0.16) -1.28 (-2.35, -0.22)* -1.32 (-2.36, -0.28)* <0.001 
Model 1† Reference (0) 0.54 (0.03, 1.05)* -0.16 (-0.61, 0.3) -0.80 (-1.82, 0.22) -0.86 (-1.85, 0.14) 0.001 
LDL-cholesterol, mmol/l       
Crude Reference (0) -0.02 (-0.06, 0.01) -0.02 (-0.05, 0.01) -0.08 (-0.14, -0.01)* -0.09 (-0.15, -0.02)* <0.001 
Model 1† Reference (0) -0.01 (-0.04, 0.03) -0.03 (-0.06, 0.001) -0.07 (-0.13, 0.001) -0.07 (-0.13, -0.002)* 0.008 
HDL-cholesterol, mmol/l       
Crude Reference (0) -0.004 (-0.02, 0.02) 0.01 (-0.01, 0.03) 0.01 (-0.03, 0.05) 0 (-0.04, 0.03) 0.48 
Model 1† Reference (0) -0.002 (-0.02, 0.02) 0.01 (-0.01, 0.02) -0.01 (-0.04, 0.03) -0.01 (-0.04, 0.03) 0.87 
Triglycerides, mmol/l       
Crude Reference (0) 0.07 (0.01, 0.13)* -0.06 (-0.11, -0.004)* -0.08 (-0.19, 0.04) -0.10 (-0.22, 0.01) <0.001 
Model 1† Reference (0) 0.06 (0.0009, 0.12)* -0.05 (-0.1, 0.003) -0.02 (-0.14, 0.10) -0.09 (-0.21, 0.02) 0.001 
Total cholesterol, mmol/l       
Crude Reference (0) -0.02 (-0.08, 0.03) -0.02 (-0.07, 0.02) -0.05 (-0.16, 0.06) -0.11 (-0.22, -0.002)* 0.15 
Model 1† Reference (0) -0.01 (-0.07, 0.04) -0.03 (-0.08, 0.02) -0.03 (-0.14, 0.08) -0.1 (-0.21, 0.005) 0.10 
Fasting glucose, mmol/l       
Crude Reference (0) 0.01 (-0.06, 0.09) 0.01 (-0.05, 0.08) 0.02 (-0.13, 0.16) 0.16 (0.01, 0.30)* 0.20 
Model 1† Reference (0) -0.02 (-0.08, 0.05) 0 (-0.05, 0.06) 0.03 (-0.1, 0.16) 0.04 (-0.09, 0.17) 0.36 
Body mass index, kg/m2       
Crude Reference (0) 0.1 (-0.06, 0.25) -0.25 (-0.39, -0.11)*** -0.17 (-0.48, 0.14) -0.11 (-0.41, 0.2) 0.001 
Model 1† Reference (0) 0.06 (-0.1, 0.21) -0.2 (-0.33, -0.06)** -0.02 (-0.32, 0.29) 0.04 (-0.26, 0.34) 0.08 
Waist circumference, cm       
Crude Reference (0) 0.67 (0.25, 1.1) -0.32 (-0.7, 0.05) -0.47 (-1.32, 0.37) 0.16 (-0.67, 0.99) 0.002 
Model 1† Reference (0) 0.25 (-0.16, 0.66) -0.28 (-0.64, 0.08) -0.16 (-0.97, 0.65) 0.18 (-0.61, 0.97) 0.16 
†: adjusted for sex, age, education, occupation, family income, smoking status, physical activity, alcohol drinking, self-rated health and chronic disease history 
(diabetes, hypertension and dyslipidemia).  
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ESM Table 4. Adjusted hazards ratios (HR) and 95% confidence interval (CI) of all-cause mortality for baseline egg consumption in 27,963 participants (61 
participants consuming more than 1 egg/day were excluded)  
 Egg consumption, number per week 
 <1 1-2 3-4 5-6 7 
Person-years 57402 120820 60979 13800 21770 
All-cause      
No. of deaths 614 1120 580 127 234 
Mortality rate, per 10,000 person-year 107 92.7 95.1 92 107.5 
Adjusted HR (95% CI)† 1.00 1.00 (0.91, 1.11) 0.99 (0.88, 1.12) 0.89 (0.73, 1.08) 1.07 (0.91, 1.25) 
Cardiovascular disease       
No. of deaths 201 371 185 40 73 
Mortality rate, per 10,000 person-year 35 30.7 30.3 29 33.5 
Adjusted HR (95% CI)† 1.00 1.09 (0.91, 1.3) 1.04 (0.85, 1.28) 0.88 (0.62, 1.26) 1.06 (0.8, 1.4) 
Ischemic heart disease       
No. of deaths 83 166 90 16 32 
Mortality rate, per 10,000 person-year 14.5 13.7 14.8 11.6 14.7 
Adjusted HR (95% CI)† 1.00 1.16 (0.89, 1.53) 1.20 (0.88, 1.63) 0.87 (0.5, 1.51) 1.07 (0.7, 1.65) 
All Stroke       
No. of deaths 84 146 69 16 24 
Mortality rate, per 10,000 person-year 14.6 12.1 11.3 11.6 11 
Adjusted HR (95% CI)† 1.00 1.01 (0.77, 1.33) 0.91 (0.66, 1.27) 0.82 (0.47, 1.43) 0.85 (0.53, 1.35) 
†: adjusted for sex, age, education, occupation, family income, smoking status, physical activity, alcohol drinking, self-rated health and chronic disease history 
(diabetes, hypertension and dyslipidemia).  
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ESM Table 5. Adjusted hazards ratios (HR) and 95% confidence interval (CI) of all-cause mortality for baseline egg consumption by education‡ in 28,024 
participants  
 Egg consumption, number per week 
 <1 1-2 3-4 5-6 7+ 
Low education (Illiterate or primary school)  
Person-years 31,294 51,451 24,172 5,258 6,588 
All-cause      
No. of deaths 410 613 286 63 76 
Mortality rate, per 10,000 person-year 131 119 118 120 115 
Adjusted HR (95% CI) 1.00 1.00 (0.88, 1.14) 0.97 (0.83, 1.13) 0.9 (0.69, 1.19) 0.94 (0.73, 1.2) 
Cardiovascular disease       
No. of deaths 150 225 98 21 25 
Mortality rate, per 10,000 person-year 48 44 41 40 38 
Adjusted HR (95% CI) 1.00 1.06 (0.85, 1.31) 0.95 (0.73, 1.24) 0.85 (0.53, 1.36) 0.82 (0.52, 1.27) 
Ischemic heart disease       
No. of deaths 60 95 47 8 14 
Mortality rate, per 10,000 person-year 19 18 19 15 21 
Adjusted HR (95% CI) 1.00 1.1 (0.79, 1.53) 1.11 (0.75, 1.65) 0.75 (0.34, 1.65) 1.11 (0.61, 2.04) 
All Stroke       
No. of deaths 61 93 36 11 10 
Mortality rate, per 10,000 person-year 19 18 15 21 15 
Adjusted HR (95% CI) 1.00 1.05 (0.75, 1.46) 0.84 (0.55, 1.28) 1.1 (0.57, 2.09) 0.77 (0.38, 1.56) 
Relatively high education (secondary school, and college or above)  
Person-years 135,877 142,459 139,507 134,424 136,831 
All-cause      
No. of deaths 1,040 1,098 1,089 1,021 1,054 
Mortality rate, per 10,000 person-year 77 77 78 76 77 
Adjusted HR (95% CI) 1.00 1.01 (0.86, 1.19) 1.03 (0.86, 1.23) 0.88 (0.66, 1.17) 1.2 (0.98, 1.47) 
Cardiovascular disease       
No. of deaths 300 318 313 294 304 
Mortality rate, per 10,000 person-year 22 22 22 22 22 
Adjusted HR (95% CI) 1.00 1.13 (0.83, 1.54) 1.15 (0.82, 1.62) 1.03 (0.61, 1.74) 1.41 (0.96, 2.06) 
Ischemic heart disease       
No. of deaths 141 153 150 139 142 
Mortality rate, per 10,000 person-year 10 11 11 10 10 
Adjusted HR (95% CI) 1.00 1.31 (0.82, 2.09) 1.36 (0.82, 2.26) 1.16 (0.54, 2.51) 1.33 (0.74, 2.4) 
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All Stroke       
No. of deaths 109 114 114 105 111 
Mortality rate, per 10,000 person-year 8 8 8 8 8 
Adjusted HR (95% CI) 1.00 0.92 (0.57, 1.49) 0.96 (0.56, 1.62) 0.56 (0.21, 1.48) 0.97 (0.52, 1.82) 
†: adjusted for sex, age, occupation, family income, smoking status, physical activity, alcohol drinking, self-rated health and chronic disease history (diabetes, 
hypertension and dyslipidemia).  
‡: P for interaction between egg consumption and education ranged 0.65 to 0.97 
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ESM Table 6 Details of studies in the meta-analysis 
Study  First author 
(year) 
Setting Total sample Events(number) Age range of 
participants 
Main findings HR (95% CI) 
1 Hu 1999[30] USA 37,851 men and 
80,082 
women  
CHD (866 in men and 939 in 
women) 
Stroke (258 in men and 563 
in women) 
Men: 40-75  
Women: 34-59 
IHD: 
Men HR=1.08 (0.79-1.48) 
Women HR=0.82 (0.60-1.13) 
All stroke: 
Men HR=1.07 (0.66-1.75) 
Women HR=0.89 (0.60-1.31) 
Ischemic stroke: 
Men HR=0.93 (0.46-1.87) 
Women HR=0.81 (0.46-1.42) 
Haemorrhagic stroke: 
Men HR=1.07 (0.66-1.75) 
Women HR=1.07 (0.56-2.03) 
2 He 2003[36] USA 43,732 men 455 ischemic strokes; 125 
haemorrhagic stokes 
40-75 Ischemic stroke: 
HR=1.09 (0.69-1.71) 
Haemorrhagic stroke: 
HR=0.32 (0.07-1.37) 
3 Sauvaget 
2003[14] 
Japan 37,130 Stroke (1462) 34-103 HR=0.70 (0.51-0.95) 
4 Nakamura 
2004[13] 
Japan 5,186 women and 
4,077 men 
IHD (39 in men and 41 in 
women) 
Stroke (112 in men and 107 
in women) 
 
30+ IHD: 
Men HR=0.93 (0.50-1.87) 
Women HR=0.86 (0.62-1.40) 
All stroke: 
Men HR=1.03 (0.67-1.53) 
Women HR=1.11 (0.74-1.48) 
All cause  
Men HR=1.15 (0.88-1.28) 
Women HR=1.01 (0.88-1.15) 
5 Nakamura 
2006[12] 
Japan 90,735 IHD (462) 40-69 HR=0.93 (0.84-1.11) 
 
6 Qureshi 
2007[37] 
USA 9,734 IHD (1584) 
Stroke (655) 
25-74 IHD: 
HR=1.1 (0.90-1.30) 
All stroke: 
HR=0.9 (0.70-1.10) 
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All cause  
HR=1.0 (0.90-1.10) 
7 Djousse 
2008[38] 
USA 21,327 men  MI (1550) 
Stroke (1342) 
40-85 MI: 
HR=0.90 (0.72-1.14) 
All stroke: 
HR=0.99 (0.80-1.20) 
All cause  
HR=1.23 (1.11-1.36) 
8 Scrafford 
2011[32] 
USA 6,833 men and 8,113 
women 
IHD (366) 
Stroke (137) 
17+ IHD: 
Men HR=1.13 (0.61-2.11) 
Women HR=0.92 (0.27-3.11) 
All stroke: 
Men HR=0.27 (0.10-0.73) 
Women HR=1.03 (0.25-4.22) 
9 Bernstein 
2012[39] 
USA 84,010 women and 
43,150 men 
Stroke (2633 in women and 
1397 in men) 
Men: 40-75 years 
Women: 30-55 
All stroke: 
Men HR=0.84 (0.68-1.04) 
Women HR=0.91 (0.80-1.04) 
Ischemic stroke: 
Men HR=0.79 (0.61-1.04) 
Women HR=0.95 (0.79-1.14) 
Haemorrhagic stroke: 
Men HR=0.53 (0.22-1.25) 
Women HR=0.76 (0.47-1.23) 
10 Larsson 
2015[24] 
Sweden 37,766 men  
 and 32,805 women 
MI (3,262 in men &1,504 in 
women); ischemic strokes 
(2,039 in men and 1,561 in 
women);  
haemorrhagic strokes (405 in 
men 
and 294 in women) 
men 45-79y and 
women 49-83 y 
MI: 
Men HR=1.03 (0.84-1.27) 
Women HR=0.85 (0.59-1.23) 
Ischemic stroke: 
Men HR=0.87 (0.66-1.14) 
Women HR=1.06 (0.76-1.47) 
Haemorrhagic stroke: 
Men HR=1.05 (0.59-1.88) 
Women HR=0.96 (0.44-2.12) 
11 Virtanen 
2016[23] 
Finland 1,032 men 230 IHD 42-60 HR=1.18 (0.85-1.66) 
HR=hazard ratio; CI=confidence interval; USA=United States of America; IHD=ischemic stroke; MI=myocardial infarction 
 
 
41 
 
30,430 Participants from 2003-2008
• Phase 1 N=10,381 (2003-4)
• Phase 2 N=10,000 (2005-6)
• Phase 3 N=10,049 (2006-8)
Excluding participants with: 
• missing information on egg 
consumption (n=153) and 
CVD risk factors (n=373); 
• previous CVD history 
(n=1520)
Total No.=28,384 
• Detailed assessment on 7-day 
FFQ in Phase 1 and 2 (N=18,999)
• Shortened FFQ in Phase 3 
(N=9,385)
• Final No. included in main data 
analysis: N=28,024
• Sensitivity analysis including 
dietary energy intake: N=18,707 
(67%) 
Loss-to-follow-up: 360 unknown 
vital status 
No. of deaths: 2,685
• Cardiovascular disease: 873
• Stroke: 341
 
 
ESM Figure 1. Study sample selection. 
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ESM Figure 2. Pooled HRs and 95% CIs of all-cause mortality including results from the Guangzhou 
Biobank Cohort Study (GBCS). The pooled estimates were obtained by using a random effect model for 
model (A), and fixed effect model for model (B). The study by Djousse et al. 2008[38] which contributed 
most to heterogeneity were excluded in model (B). The dots indicate the adjusted HRs from a comparison 
of the highest category of egg consumption (≥7 eggs/week) with the lowest (<1 egg/week or never). The 
size of the square is proportional to the weight of individual study. The horizontal lines represent 95% CI. 
The diamond data markers indicate the pooled HR.  
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ESM Figure 3: Test for publication bias for the association between egg intake and all-cause mortality, 
ischemic heart disease, and stroke and its subtypes 
Note: Tests for publication bias: (1) Begg’s test, P=0.33, 0.90, 0.87, 0.53 and 0.18 for all-cause mortality, 
IHD, stroke, ischemic stroke and hemorrhagic stroke, respectively; (2) Egger’s test, P=0.74, 0.86, 0.57, 
0.61, 0.36 for all-cause mortality, IHD, stroke, ischemic stroke and hemorrhagic stroke, respectively. 
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